We investigated the association between the PD-L1 and PD-L2 copy number gains and expression levels of the corresponding proteins, clinicopathological characteristics, other oncogenic alterations, and survival outcomes in a large cohort of 654 patients with resected NSCLC. This evidence concerns the gene CD274 and non-small cell lung carcinoma.